- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05870176
ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors
ActivityChoice: A Clinic-delivered Implementation Program to Increase Physical Activity and Decrease Cardiovascular Disease Risk Amongst Cancer Survivors
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01605
- University of Massachusetts Chan Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
AIM 1 Inclusion Criteria for Aim 1a
- Prior cancer diagnosis
- 18 years of age and older
- Speaks English
Exclusion Criteria for Aim 1a
- No prior cancer diagnosis
- Under 18 years of age
- Prisoners
- Does not speak English
AIM1B Survivor Inclusion Criteria for Aim 1b
- Prior cancer diagnosis
- 18 years of age and older
- Speaks English
Survivor Exclusion Criteria for 1b
- No prior cancer diagnosis
- Under 18 years of age
- Does not speak English
- Prisoners
- Participated in Aim 1a
Clinic Staff Inclusion Criteria for Aim 1b
- Provide cancer care for patients at one of the four UMass cancer clinics,
- Involved in survivorship care planning visits
- Speaks English
- 18 years of age and older
Clinic Staff Exclusion Criteria for 1b
- Is not employed at one of the four UMass cancer clinics
- Is not involved in survivorship care planning visits
- Does not speak English
- Prisoners
- Under 18 years of age
Pregnant Women Pregnant women may be included in this study as an incidental population.
AIM 2 Clinic Staff Inclusion Criteria for Aim 2
- Provide cancer care for patients at one of the four UMass cancer clinics
- Involved in survivorship care visits
- Speaks English
- 18 years of age and older
Clinic Staff Exclusion Criteria for Aim 2
- Is not employed at one of the four UMass cancer clinics
- Is not involved in survivorship care visits
- Does not speak English
- Prisoners
- Under 18 years of age
Survivor Inclusion Criteria for Aim 2
- Cancer Patient at one of the four UMass cancer clinics
- Has a survivorship care planning visit
- Able to perform physical activity
- Completes Physical Activity Readiness Questionnaire (PAR-Q) physical activity readiness questionnaire or has medical clearance to participate
- Has a smartphone
- Speaks English
- 18 years of age and older
Survivor Exclusion Criteria for Aim 2:
- Not a cancer patient at one of the four UMass cancer clinics
- Does not have a survivorship care planning visit
- Unable to perform physical activity or no medical clearance to participate
- Does not speak English
- Under 18 years of age
- Does not have a smartphone
- Prisoners
- Is pregnant
AIM 3 Clinic Staff Inclusion Criteria for Aim 3
- Are enrolled in ActivityChoice
- ≥ 18 years of age
- Provide written informed consent
Patient Inclusion Criteria for Aim 3
- Are enrolled in ActivityChoice
- Had a clinic visit with one of the enrolled clinic staff during the study period
- ≥ 18 years of age
- Speaks English
- Provide written informed consent
Patient Exclusion Criteria for Aim 3
- Not enrolled in ActivityChoice
- Was not seen in the clinic by an enrolled clinic staff during the study period
UMass Cancer Clinic Administration Inclusion Criteria for Aim 3
- Are ≥ 18 years of age
- Are in positions of cancer center leadership
- Provide written informed consent
UMass Cancer Clinic Administration Exclusion Criteria for Aim 3
- Unable or unwilling to provide written informed consent
- Not in positions of leadership within the UMass Medical Cancer Clinic Administration
- <18 years of age.
External site stakeholders Inclusion Criteria for Aim 3
- Are ≥18 years of age
- Are in positions of cancer center leadership
- Provide written informed consent.
External site stakeholders Exclusion Criteria for Aim 3
- Unable or unwilling to provide written informed consent
- Not in positions of leadership overseeing cancer survivorship
- <18 years of age.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard Referral
Provider education/training on referral process Patient education material on physical activity benefits Paper referral to LIVESTRONG at the YMCA Fitbit Activity Monitor
|
The standard referral period will serve as the "usual care" comparator.
Patients will receive a paper referral and Fitbit monitor.
|
|
Experimental: Enhanced Referral
Provider education/training on referral process Patient education material on physical activity benefits Patient decision aid on physical activity program choices Electronic referral to program of patient's choice Fitbit Activity Monitor
|
The enhanced referral uses an electronic referral and patient decision aid to provide choices to 3 different physical activity programs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients referred as obtained by the electronic referral system and electronic health record
Time Frame: Baseline
|
The number of patients referred/The number of eligible patients
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of eligible clinicians enrolling in the the study
Time Frame: Baseline
|
Number of enrolled clinicians/Number of eligible clinicians
|
Baseline
|
|
Clinic/Clinician fidelity of delivering patient decision aids
Time Frame: Baseline
|
Clinic delivery of patient decision aids as reported by patients
|
Baseline
|
|
Patient Engagement
Time Frame: Examined at baseline, 3-, and 6-months
|
Program enrollment (number referred/number enrolled);
|
Examined at baseline, 3-, and 6-months
|
|
Patient Retention
Time Frame: 3- and 6-months
|
Percent of enrolled patients completing follow-up surveys at 3- and 6-months
|
3- and 6-months
|
|
Patient narrative decision aid acceptability and effectiveness (Enhanced Referral only)
Time Frame: Baseline following referrals
|
Acceptability of decision aid using the Ottawa Decision Aid Centre 10-item acceptability of decision aids (Minimum score=0, Maximum score=100; Higher score indicates higher decisional conflict and uncertainty
|
Baseline following referrals
|
|
Patient Autonomous Regulation
Time Frame: Baseline, 3- and 6-months
|
Behavioral Regulation for Exercise Questionnaire-2 (Minimum=0, Maximum=76; Higher scores indicates greater regulation/motivation)
|
Baseline, 3- and 6-months
|
|
Patient Objective Physical Activity
Time Frame: Baseline, 3- and 6-months
|
Change from baseline to 3- and 6-months in steps, light, moderate and vigorous physical activity measured via Fitbits.
|
Baseline, 3- and 6-months
|
|
Patient Self-Report Physical Activity
Time Frame: Baseline, 3- and 6-months
|
Change from baseline to 3- and 6-months in light, moderate and vigorous physical activity survey-measured (Godin leisure time questionnaire) physical activity.
The questionnaire is a 4-item self-administered questionnaire with the first three questions seeking information on the number of times one engages in mild, moderate and strenuous leisure-time physical activity bouts of at least 15 min duration in a typical week.
Scores can range from 0 to 98, with the higher score meaning a greater level of activity for that week.
|
Baseline, 3- and 6-months
|
|
Patient Health-related Quality of Life
Time Frame: Baseline, 3- and 6-months
|
Functional Assessment of Cancer Therapy-General (FACT-G): Physical, social, emotional and functional well-being (Minimum=0, Maximum=127; Higher score means a higher quality of life)
|
Baseline, 3- and 6-months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinician, Patient, Leadership, and External Partner Acceptability
Time Frame: At study completion, within 3 months of enrollment
|
Semi-structured interviews using interview guides with enrolled clinicians, referred survivors, clinic leadership, and external partners
|
At study completion, within 3 months of enrollment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jamie M Faro, PhD, UMass Chan Medical School
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00000522
- 1K01HL163254 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Standard Referral
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); AstraZenecaCompletedMyocardial Infarction | Coronary Disease | Unstable AnginaCanada
-
RTI InternationalNational Institute of Mental Health (NIMH)Completed
-
Columbia UniversitySociety of Family PlanningCompleted
-
Monash University MalaysiaMonash UniversityCompletedHypertension | Behavior and Behavior MechanismsMalaysia
-
Brown UniversityNational Institute of Mental Health (NIMH)CompletedPsychotic Disorders | Psychosis Nos/OtherUnited States
-
University of British ColumbiaInterior Health; Retired Teachers of Ontario FoundationCompleted
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed
-
University of ArkansasDuke University; National Institutes of Health (NIH); University of KentuckyRecruitingHearing LossUnited States
-
Tulip MedicineCompletedRehabilitation | Hip Osteoarthritis | Hip Arthroplasty Replacement | Hip Arthroplasty, TotalKazakhstan